POLYMYOSITIS, DERMATOMYOSITIS

Clinical trials for POLYMYOSITIS, DERMATOMYOSITIS explained in plain language.

Never miss a new study

Get alerted when new POLYMYOSITIS, DERMATOMYOSITIS trials appear

Sign up with your email to follow new studies for POLYMYOSITIS, DERMATOMYOSITIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New injection aims to tame rare, debilitating muscle diseases

Disease control Recruiting now

This study is testing whether adding a new injectable drug, anifrolumab, to standard treatment can better control disease activity in adults with polymyositis or dermatomyositis. It will involve about 240 participants who will receive either the drug or a placebo injection for a …

Matched conditions: POLYMYOSITIS, DERMATOMYOSITIS

Phase: PHASE3 • Sponsor: AstraZeneca • Aim: Disease control

Last updated Mar 25, 2026 14:08 UTC

POLYMYOSITIS, DERMATOMYOSITIS

Get alerted when new POLYMYOSITIS, DERMATOMYOSITIS trials appear

New injection aims to tame rare, debilitating muscle diseases